𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer

✍ Scribed by Abel Sanchez-Palencia; Mercedes Gomez-Morales; Jose Antonio Gomez-Capilla; Vicente Pedraza; Laura Boyero; Rafael Rosell; Mª Esther Fárez-Vidal

Publisher
John Wiley and Sons
Year
2010
Tongue
French
Weight
418 KB
Volume
129
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The development of reliable gene expression profiling technology is having an increasing impact on our understanding of lung cancer biology. Our study aimed to determine any correlation between the phenotypic heterogeneity and genetic diversity of lung cancer. Microarray analysis was performed on a set of 46 tumor samples and 45 paired nontumor samples of nonsmall cell lung cancer (NSCLC) samples to establish gene signatures in primary adenocarcinomas and squamous‐cell carcinomas, determine differentially expressed gene sequences at different stages of the disease and identify sequences with biological significance for tumor progression. After the microarray analysis, the expression level of 92 selected genes was validated by qPCR and the robust Bonferroni test in an independent set of 70 samples composed of 48 tumor samples and 22 nontumor samples. Gene sequences were differentially expressed as a function of tumor type, stage and differentiation grade. High upregulation was observed for KRT15 and PKP1, which may be good markers to distinguish squamous‐cell carcinoma samples. High downregulation was observed for DSG3 in stage IA adenocarcinomas.

📜 SIMILAR VOLUMES

Circulating micro-RNA expression profile
Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer
✍ Niels H.H. Heegaard; Aaron J. Schetter; Judith A. Welsh; Mitsuhiro Yoneda; Elise 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 341 KB 👁 1 views

## Abstract Circulating micro‐RNA (miR) profiles have been proposed as promising diagnostic and prognostic biomarkers for cancer, including lung cancer. We have developed methods to accurately and reproducibly measure micro‐RNA levels in serum and plasma. Here, we study paired serum and plasma samp

Expression of multiple epigenetically re
Expression of multiple epigenetically regulated cancer/germline genes in nonsmall cell lung cancer
✍ Carolin Grunwald; Michael Koslowski; Tülin Arsiray; Karl Dhaene; Marleen Praet; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 237 KB 👁 2 views

## Abstract Cancer/germline (CG) antigens represent promising targets for widely applicable mono‐ and multiantigen cancer vaccines for nonsmall cell lung cancer (NSCLC). Since little is known about their composite expression in this tumor type, we analyzed 7 CG genes (__MAGE‐A3__, __NY‐ESO‐1__, __L

Inactivation of LLC1 gene in nonsmall ce
Inactivation of LLC1 gene in nonsmall cell lung cancer
✍ Kyeong-Man Hong; Sei-Hoon Yang; Sinchita Roy Chowdhuri; Audrey Player; Megan Ham 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 448 KB 👁 2 views

## Abstract Serial analysis of gene expression studies led us to identify a previously unknown gene, c20orf85, that is present in the normal lung epithelium but absent or downregulated in most primary nonsmall cell lung cancers and lung cancer cell lines. We named this gene __LLC1__ for __L__ow in